The long-awaited update to guidelines for the management of hypertension - from the panel appointed to the Eighth Joint National Committee (JNC 8) - raises the recommended blood pressure threshold to determine the need for drug therapy in many patients.
The long-awaited update to guidelines for the management of hypertension -- from the panel appointed to the Eighth Joint National Committee (JNC 8) -- raises the recommended blood pressure threshold to determine the need for drug therapy in many patients.
For most hypertensive individuals 60 or older, pharmacologic treatment should be started when the systolic pressure is 150 mm Hg or higher or the diastolic pressure is 90 mm Hg or higher, with the goal of achieving readings below those cutoffs, according to the new recommendations.
For younger hypertensive patients and for those with chronic kidney disease or diabetes -- regardless of age -- treatment should be initiated when the systolic pressure is 140 or higher or the diastolic pressure is 90 or higher.
Read the full story here: http://bit.ly/1fF22wB
Source: Med Page Today
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen